TRANSGENOMIC is a global biotechnology company advancing personalized medicine in oncology and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD PCR, which enables use of liquid biopsies for mutation detection. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Transgenomic s diagnostic technologies are designed to improve medical diagnoses and patient outcomes..
Quote | Precipio Inc. (NASDAQ:PRPO)
Last: | $5.54 |
---|---|
Change Percent: | -4.9% |
Open: | $5.518 |
Close: | $5.54 |
High: | $5.6 |
Low: | $5.19 |
Volume: | 17,076 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Precipio Inc. (NASDAQ:PRPO)
NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that its unaudited non-GAAP Cash Burn/Generated from Operations (CBFO) for Q2-2024 was $0.3M of cash generated for the quarter. It is important to not...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
Message Board Posts | Precipio Inc. (NASDAQ:PRPO)
Subject | By | Source | When |
---|---|---|---|
after having sold all my shares up to | PennyStockTrader2 | investorshub | 04/06/2023 6:13:31 PM |
whytestocks: $TBIO News Article - Telesis Bio Releases BioXp Select Kits to Enable DNA Amplification | whytestocks | investorshangout | 03/31/2023 2:30:51 PM |
whytestocks: $TBIO News Article - Telesis Bio to Present at Festival of Biologics Conference | whytestocks | investorshangout | 03/16/2023 12:10:56 PM |
whytestocks: $TBIO News Article - Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial | whytestocks | investorshangout | 03/09/2023 9:35:46 PM |
znewcar1: $PRPO ML=LL.47 HOD.7733 nice curl. | znewcar1 | investorshangout | 01/17/2023 4:02:50 AM |
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that its unaudited non-GAAP Cash Burn/Generated from Operations (CBFO) for Q2-2024 was $0.3M of cash generated for the quarter. It is important to not...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...